세계의 바이오슬랙스(Biothrax) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Biothrax is a vaccine designed to protect against anthrax, a serious and potentially fatal illness caused by the bacterium Bacillus anthracis. The vaccine stimulates the immune system to produce antibodies against anthrax toxins, which can be lethal if exposure occurs, particularly in bioterrorism scenarios.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types in the biothrax market are live vaccines and cell-free protective antigen vaccines. Live vaccines are made from weakened (attenuated) organisms that do not cause disease but effectively trigger a strong immune response. The clinical indications include pre-exposure prophylaxis and post-exposure prophylaxis. The vaccine is used for both human and animal applications, with end users including hospitals, clinics, vaccination centers, and others.

The biothrax market research report is one of a series of new reports from The Business Research Company that provides biothrax market statistics, including biothrax industry global market size, regional shares, competitors with a biothrax market share, detailed biothrax market segments, market trends, and opportunities, and any further data you may need to thrive in the biothrax industry. This biothrax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biothrax market size is expected to see strong growth in the next few years. It will grow to $1,300 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to rising bioterrorism concerns, increased government defense spending, expansion of global biodefense programs, advancements in vaccine technology, growing public health preparedness initiatives. Major trends in the forecast period include increased government and military investments, expansion of biodefense initiatives, improvement in vaccine delivery systems, rising awareness of bioterrorism risks, strategic partnerships and collaborations.

Increasing consumption of meat is expected to drive the growth of the biothrax market. Meat consumption is influenced by factors such as urbanization, rising income levels, evolving dietary preferences, and cultural traditions that emphasize meat as a primary source of protein and nutrition. BioThrax is used to vaccinate livestock against anthrax, a disease that can spread through contaminated meat, ensuring the safety of meat products and protecting public health from zoonotic disease outbreaks. For instance, the Food and Agriculture Organization (FAO) reported a 1.96% increase in global meat production from 356.9 million metric tons in 2021 to 363.9 million metric tons in 2023, with bovine meat production rising from 74.9 million metric tons in 2021 to 76.1 million metric tons in 2023. Thus, the rising meat consumption is driving the growth of the biothrax market.

Growing prevalence of anthrax is expected to propel the growth of the biothrax market. Anthrax is primarily caused by Bacillus anthracis spores found in soil. BioThrax, a vaccine that helps prevent anthrax, stimulates the immune system to produce antibodies against Bacillus anthracis. For example, as of November 2023, Zambia reported 684 suspected human cases of anthrax, including four deaths, according to the World Health Organization (WHO). The prevalence of anthrax is driving the need for vaccines such as biothrax to combat the disease and protect public health.

A key trend in the biothrax market is the focus on strategic investments to enhance production capabilities, expand geographic presence, and develop advanced anthrax vaccines. Strategic funding supports clinical trials and regulatory compliance, allowing companies to gain approvals across multiple regions and expand vaccine availability to underserved areas. For instance, in January 2024, Emergent BioSolutions, a US-based biotech company, secured a contract worth up to $235.8 million from the U.S. Department of Defense (DoD) to supply BioThrax for military use. This contract highlights the continued demand for anthrax vaccines and underscores Emergent's long-standing relationship with the U.S. government in providing biodefense solutions.

Major players operating in the biothrax market are Emergent Bio-Solutions.

North America was the largest region in the biothrax market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biothrax report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biothrax market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biothrax market consists of sales of single-dose vials and multi-dose vials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biothrax Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biothrax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biothrax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biothrax market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Live Vaccines; Cell Free Protective Antigen Vaccines
• 2) By Clinical Indication: Pre-Exposure Prophylaxis; Post-Exposure Prophylaxis
• 3) By Application: Human Use; Animal Use
• 4) By End-User: Hospital; Clinics; Vaccination Centers; Other End-Users
• Companies Mentioned: Emergent Bio-Solutions
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biothrax Market Characteristics

3. Biothrax Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Biothrax Market Trends And Strategies

5. Biothrax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Biothrax Growth Analysis And Strategic Analysis Framework

• 6.1. Global Biothrax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Biothrax Market Growth Rate Analysis
• 6.4. Global Biothrax Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Biothrax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Biothrax Total Addressable Market (TAM)

7. Global Biothrax Market Pricing Analysis & Forecasts

8. Biothrax Market Segmentation

• 8.1. Global Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Vaccines
• Cell Free Protective Antigen Vaccines
• 8.2. Global Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-exposure Prophylaxis
• Post-exposure Prophylaxis
• 8.3. Global Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Use
• Animal Use
• 8.4. Global Biothrax Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinics
• Vaccination Centers
• Other End-Users

9. Global Biothrax Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Biothrax Market Regional And Country Analysis

• 10.1. Global Biothrax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Biothrax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Biothrax Market

• 11.1. Asia-Pacific Biothrax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Biothrax Market

• 12.1. China Biothrax Market Overview
• 12.2. China Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Biothrax Market

• 13.1. India Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Biothrax Market

• 14.1. Japan Biothrax Market Overview
• 14.2. Japan Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Biothrax Market

• 15.1. Australia Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Biothrax Market

• 16.1. South Korea Biothrax Market Overview
• 16.2. South Korea Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Biothrax Market

• 17.1. Western Europe Biothrax Market Overview
• 17.2. Western Europe Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Biothrax Market

• 18.1. UK Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Biothrax Market

• 19.1. Germany Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Biothrax Market

• 20.1. France Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biothrax Market

• 21.1. Eastern Europe Biothrax Market Overview
• 21.2. Eastern Europe Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Biothrax Market

• 22.1. North America Biothrax Market Overview
• 22.2. North America Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Biothrax Market

• 23.1. USA Biothrax Market Overview
• 23.2. USA Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Biothrax Market

• 24.1. Canada Biothrax Market Overview
• 24.2. Canada Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Biothrax Market

• 25.1. South America Biothrax Market Overview
• 25.2. South America Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Biothrax Market

• 26.1. Middle East Biothrax Market Overview
• 26.2. Middle East Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Biothrax Market

• 27.1. Africa Biothrax Market Overview
• 27.2. Africa Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Biothrax Market Competitive Landscape And Company Profiles

• 28.1. Biothrax Market Competitive Landscape
• 28.2. Biothrax Market Company Profiles
  • 28.2.1. Emergent Bio-Solutions Overview, Products and Services, Strategy and Financial Analysis

29. Global Biothrax Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Biothrax Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Biothrax Market

32. Recent Developments In The Biothrax Market

33. Biothrax Market High Potential Countries, Segments and Strategies

• 33.1 Biothrax Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Biothrax Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Biothrax Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer